Flobow Facial Bump Refining Essence

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the improvement of skin texture through gentle exfoliation. It is designed to aid in the smoothing of the skin, making it suitable for individuals seeking to enhance the overall appearance and feel of their skin.

Dosage and Administration

Healthcare professionals are advised to instruct patients to apply the product daily after cleansing and toning the skin. For optimal results, the product should be used twice a day for a minimum duration of 4 weeks.

A pea-sized amount of the essence should be dispensed onto the affected area. Patients should use their fingertips to gently massage the essence into the skin until it is fully absorbed. Continued use is recommended until the appearance of skin papules is resolved and does not recur.

Contraindications

Use is contraindicated in children under 2 years of age due to the potential for adverse effects in this population. Additionally, application on open skin wounds is contraindicated to prevent the risk of infection and other complications associated with compromised skin integrity.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to discontinue use and seek medical attention if any rash or irritation develops. It is crucial to monitor for signs of irritation or rash during treatment, as these may indicate an adverse reaction.

In the event of accidental ingestion, immediate medical assistance should be sought. Patients should be instructed to contact the Poison Control Center without delay to ensure appropriate management and care.

Side Effects

Patients should be aware that the product is intended for external use only. In the event of rash or irritation, it is advised to discontinue use and consult a healthcare professional. This recommendation is reinforced by clinical observations, which indicate that irritation or rash may occur in some individuals.

Participants in clinical trials have reported instances of irritation and rash, underscoring the importance of monitoring for these adverse reactions. Should any signs of irritation or rash develop, it is crucial for patients to stop using the product and seek medical advice.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Flobow Facial Bump Refining Essence (salicylic acid 1% facial bump refining essence). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not be administered this medication. Safety and efficacy have not been established in this age group, and caution is advised when considering treatment options for younger children.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of FLOBOW FACIAL BUMP REFINING ESSENCE during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Healthcare professionals should consider this lack of data when advising women of childbearing potential and weigh the potential risks and benefits before recommending this product during pregnancy.

Lactation

There is no information available regarding the use of FLOBOW FACIAL BUMP REFINING ESSENCE in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider this lack of data when advising lactating patients.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse effects that may arise. In the event of suspected overdosage, it is recommended to initiate supportive care and symptomatic treatment as necessary.

Healthcare providers should consider contacting a poison control center or a medical toxicologist for guidance on management strategies tailored to the specific situation. Continuous assessment of the patient's clinical status is essential to ensure appropriate interventions are implemented promptly.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center if the product is swallowed. It is important to inform patients that this product is not recommended for use in children under 2 years of age or on open skin wounds.

Patients should be instructed to discontinue use and consult a healthcare professional if they experience any irritation or rash. Additionally, while using the product, patients must be cautioned to avoid contact with the eyes, ears, mouth, and any open or broken skin areas. In the event of contact with the eyes, patients should rinse their eyes thoroughly with water.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, shady place to maintain its integrity and effectiveness. Proper storage conditions are crucial to ensure the product remains within the recommended temperature range, thereby preventing degradation or loss of efficacy. Special handling requirements should be observed to protect the product from exposure to direct sunlight and extreme temperatures.

Additional Clinical Information

Patients should apply the essence daily after cleansing and toning, with a recommended frequency of twice a day for a minimum of four weeks. A pea-size amount should be dispensed onto the affected area and massaged in with fingertips until fully absorbed. Continued use is advised until skin papules no longer appear.

Clinicians should counsel patients that the product is for external use only. Patients should discontinue use and consult a doctor if any rash or irritation occurs. In case of contact with eyes, thorough rinsing with water is necessary.

Drug Information (PDF)

This file contains official product information for Flobow Facial Bump Refining Essence, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)